Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abad-Rodriguez, 2004, Neuronal membrane cholesterol loss enhances amyloid peptide generation, The Journal of Cell Biology, 167, 953, 10.1083/jcb.200404149
Agarwal, 2002, Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 775, 121, 10.1016/S1570-0232(02)00273-8
Aisen, 1994, Inflammatory mechanisms in Alzheimer's disease: implications for therapy, The American Journal of Psychiatry, 151, 1105, 10.1176/ajp.151.8.1105
Arvanitakis, 2004, Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function, Archives of Neurology, 61, 661, 10.1001/archneur.61.5.661
Attia, 2010, Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities, Atherosclerosis, 209, 422, 10.1016/j.atherosclerosis.2009.09.025
Attie, 2001, Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis, Journal of Lipid Research, 42, 1717, 10.1016/S0022-2275(20)31498-X
Balazs, 2004, Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood–brain barrier model, Journal of Neurochemistry, 89, 939, 10.1111/j.1471-4159.2004.02373.x
Baldan, 2009, The ABCs of sterol transport, Journal of Lipid Research, 50, S80, 10.1194/jlr.R800044-JLR200
Berrougui, 2007, Age-related impairment of HDL-mediated cholesterol efflux, Journal of Lipid Research, 48, 328, 10.1194/jlr.M600167-JLR200
Bjorkhem, 2004, Brain cholesterol: long secret life behind a barrier, Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 806, 10.1161/01.ATV.0000120374.59826.1b
Bodovitz, 1996, Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein, The Journal of Biological Chemistry, 271, 4436, 10.1074/jbc.271.8.4436
Borggreve, 2003, Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins, European Journal of Clinical Investigation, 33, 1051, 10.1111/j.1365-2362.2003.01263.x
Clark, 2010, Oxidative stress and its implications for future treatments and management of Alzheimer disease, International Journal of Biomedical Science: IJBS, 6, 225, 10.59566/IJBS.2010.6225
Cordy, 2003, Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein, Proceedings of the National Academy of Sciences of the United States of America, 100, 11735, 10.1073/pnas.1635130100
Cuchel, 2006, Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?, Circulation, 113, 2548, 10.1161/CIRCULATIONAHA.104.475715
de la Llera-Moya, 1999, Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface, Journal of Lipid Research, 40, 575, 10.1016/S0022-2275(20)32462-7
Dietschy, 2001, Cholesterol metabolism in the brain, Current Opinion in Lipidology, 12, 105, 10.1097/00041433-200104000-00003
Engelhart, 2004, Inflammatory proteins in plasma and the risk of dementia: the rotterdam study, Archives of Neurology, 61, 668, 10.1001/archneur.61.5.668
Esteve, 2005, Dyslipidemia and inflammation: an evolutionary conserved mechanism, Clinical Nutrition, 24, 16, 10.1016/j.clnu.2004.08.004
Favari, 2004, Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein, The Journal of Biological Chemistry, 279, 9930, 10.1074/jbc.M312476200
Frisardi, 2010, Plasma lipid disturbances and cognitive decline, Journal of the American Geriatrics Society, 58, 2429, 10.1111/j.1532-5415.2010.03164.x
Gu, 2010, Structures of discoidal high density lipoproteins: a combined computational–experimental approach, The Journal of Biological Chemistry, 285, 4652, 10.1074/jbc.M109.069914
Haidar, 2002, cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts, Journal of Lipid Research, 43, 2087, 10.1194/jlr.M200235-JLR200
Hajj Hassan, 2005, Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release, Journal of Lipid Research, 46, 1457, 10.1194/jlr.M400477-JLR200
Hartmann, 2001, Cholesterol, A beta and Alzheimer's disease, Trends in Neurosciences, 24, S45, 10.1016/S0166-2236(00)01990-1
Huang, 2006, Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies, Current Opinion in Drug Discovery & Development, 9, 627
Irizarry, 2004, Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein, Journal of Neurochemistry, 90, 1132, 10.1111/j.1471-4159.2004.02581.x
Kalvodova, 2005, Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro, The Journal of Biological Chemistry, 280, 36815, 10.1074/jbc.M504484200
Khalil, 2000, Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation, Journal of Lipid Research, 41, 1552, 10.1016/S0022-2275(20)31987-8
Khalil, 1998, Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by gamma-radiolysis of water, FEBS Letters, 435, 153, 10.1016/S0014-5793(98)01058-8
Koukos, 2007, LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN, Biochemistry, 46, 10713, 10.1021/bi7003203
Laurin, 2007, Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study, Circulation, 116, 2269, 10.1161/CIRCULATIONAHA.106.686477
Lidington, 1999, A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions, Transplant Immunology, 7, 239, 10.1016/S0966-3274(99)80008-2
Ligthart, 1984, Admission criteria for immunogerontological studies in man: the SENIEUR protocol, Mechanisms of Ageing and Development, 28, 47, 10.1016/0047-6374(84)90152-0
Lutjohann, 1996, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proceedings of the National Academy of Sciences of the United States of America, 93, 9799, 10.1073/pnas.93.18.9799
Marcil, 1999, Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency, Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 159, 10.1161/01.ATV.19.1.159
McGrowder, 2011, The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer, Cholesterol, 2011, 496925, 10.1155/2011/496925
McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939
Mielke, 2010, The 32-year relationship between cholesterol and dementia from midlife to late life, Neurology, 75, 1888, 10.1212/WNL.0b013e3181feb2bf
Navab, 2006, Mechanisms of disease: proatherogenic HDL – an evolving field, Nature Clinical Practice. Endocrinology & Metabolism, 2, 504, 10.1038/ncpendmet0245
Newman, 2005, Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort, Journal of the American Geriatrics Society, 53, 1101, 10.1111/j.1532-5415.2005.53360.x
Nunomura, 2001, Oxidative damage is the earliest event in Alzheimer disease, Journal of Neuropathology and Experimental Neurology, 60, 759, 10.1093/jnen/60.8.759
Panza, 2009, Higher total cholesterol, cognitive decline, and dementia, Neurobiology of Aging, 30, 546, 10.1016/j.neurobiolaging.2007.10.019
Pfrieger, 2003, Cholesterol homeostasis and function in neurons of the central nervous system, Cellular and Molecular Life Sciences: CMLS, 60, 1158, 10.1007/s00018-003-3018-7
Puglielli, 2005, Alzheimer disease beta-amyloid activity mimics cholesterol oxidase, The Journal of Clinical Investigation, 115, 2556, 10.1172/JCI23610
Querfurth, 2010, Alzheimer's disease, The New England Journal of Medicine, 362, 329, 10.1056/NEJMra0909142
Refolo, 2000, Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model, Neurobiology of Disease, 7, 321, 10.1006/nbdi.2000.0304
Refolo, 2001, A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease, Neurobiology of Disease, 8, 890, 10.1006/nbdi.2001.0422
Reitz, 2010, Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease, Archives of Neurology, 67, 1491, 10.1001/archneurol.2010.297
Sammalkorpi, 1988, Changes in serum lipoprotein pattern induced by acute infections, Metabolism: Clinical and Experimental, 37, 859, 10.1016/0026-0495(88)90120-5
Sattler, 1994, Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence, Methods in Enzymology, 233, 469, 10.1016/S0076-6879(94)33053-0
Schneider, 2004, Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology, Neurology, 62, 1148, 10.1212/01.WNL.0000118211.78503.F5
Schonknecht, 2002, Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls, Neuroscience Letters, 324, 83, 10.1016/S0304-3940(02)00164-7
Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2
Simons, 1998, Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons, Proceedings of the National Academy of Sciences of the United States of America, 95, 6460, 10.1073/pnas.95.11.6460
Singh-Manoux, 2008, Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study, Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1556, 10.1161/ATVBAHA.108.163998
Smith, 2006, Insight into ABCG1-mediated cholesterol efflux, Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1198, 10.1161/01.ATV.0000221217.86465.66
Tan, 2007, Inflammatory markers and the risk of Alzheimer disease: the Framingham Study, Neurology, 68, 1902, 10.1212/01.wnl.0000263217.36439.da
Tansley, 2007, The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein, Journal of Lipid Research, 48, 1022, 10.1194/jlr.M600542-JLR200
Troncoso, 2008, Effect of infarcts on dementia in the Baltimore longitudinal study of aging, Annals of Neurology, 64, 168, 10.1002/ana.21413
Tschape, 2006, Therapeutic perspectives in Alzheimer's disease, Recent Patents on CNS Drug Discovery, 1, 119, 10.2174/157488906775245354
Umeda, 2010, Regulation of cholesterol efflux by amyloid beta secretion, Journal of Neuroscience Research, 88, 1985, 10.1002/jnr.22360
Van Lenten, 1995, Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures, The Journal of Clinical Investigation, 96, 2758, 10.1172/JCI118345
Wahrle, 2002, Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains, Neurobiology of Disease, 9, 11, 10.1006/nbdi.2001.0470
Wang, 2001, ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein, The Journal of Biological Chemistry, 276, 23742, 10.1074/jbc.M102348200
Weninger, 2001, Inflammation and Alzheimer disease: the good, the bad, and the ugly, Nature Medicine, 7, 527, 10.1038/87839
Wolozin, 2004, Cholesterol and the biology of Alzheimer's disease, Neuron, 41, 7, 10.1016/S0896-6273(03)00840-7
Wolozin, 2001, A fluid connection: cholesterol and Abeta, Proceedings of the National Academy of Sciences of the United States of America, 98, 5371, 10.1073/pnas.101123198
Wolozin, 2000, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, Archives of Neurology, 57, 1439, 10.1001/archneur.57.10.1439
Xiong, 2008, Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production, Neurobiology of Disease, 29, 422, 10.1016/j.nbd.2007.10.005
Yancey, 2004, SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome, Journal of Lipid Research, 45, 1724, 10.1194/jlr.M400133-JLR200
Yancey, 2003, Importance of different pathways of cellular cholesterol efflux, Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 712, 10.1161/01.ATV.0000057572.97137.DD
Ye, 2005, Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target, Proceedings of the National Academy of Sciences of the United States of America, 102, 18700, 10.1073/pnas.0508693102
Zannis, 2006, Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL, Journal of Molecular Medicine, 84, 276, 10.1007/s00109-005-0030-4